Enzo Biochem Inc. (NYSE:ENZ) today reported results for the fiscal first quarter ended October 31, 2013. Highlights include:
•Net loss for the quarter was reduced by over $0.9 million from a year ago and $0.3 million sequentially.
•Sequential revenue increased by $0.9 million, driven by strong growth in Clinical Labs, which offset continued general market weakness affecting Life Sciences.
Help employers find you! Check out all the jobs and post your resume.
